Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00733 |
| Species: | Homo sapiens |
| Position : | chr1:47669000-47669500 |
| Year: | 2014 |
| Title: | Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | T-cell acute lymphoblastic leukemia |
| PMID: | 25394790 |
| MONDO: | MONDO:0004963 |
| Tissue: | blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | Jurkat and TAL1-mutant primary T-ALL |
| CVCL ID: | CVCL_0367 |
| Cell Type: | T lymphoblast |
| Cell Ontology ID: | CL:0000084 |
| Experiment Type: | Autoregulatory oncogenic enhancer complex |
| High Throughput Method: | H3K27ac ChIP-seq; TF ChIP-seq |
| Low Throughput Method: | Reporter assay; mutation analysis |
| Target gene : | TAL1 |
| TF name : | TAL1 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_00731 | chr1:47669000-47669500 | blood | T lymphoblast | T-cell acute lymphoblastic leukemia |
| E_00732 | chr1:47669000-47669500 | blood | T lymphoblast | T-cell acute lymphoblastic leukemia |
| E_00734 | chr1:47669000-47669500 | blood | T lymphoblast | T-cell acute lymphoblastic leukemia |